Classification:
Title:
Phenobarbital
CAS NO.：
50-06-6
Summary:
GMP
Description:
Phenobarbital is a long-acting barbiturate used primarily to control seizures, including generalized tonic-clonic and partial seizures. It works by depressing the central nervous system, calming excessive neuronal activity, and stabilizing electrical impulses in the brain. In addition to its anticonvulsant properties, Phenobarbital has sedative effects, making it useful for short-term management of anxiety or insomnia under medical supervision. It is available in oral, injectable, and intravenous forms, allowing flexibility in administration. As a prescription medication, Phenobarbital should be used strictly according to a healthcare provider’s instructions. Careful monitoring is essential to avoid dependence, overdose, or adverse reactions, which may include dizziness, drowsiness, or impaired coordination.
Keywords:
Potassium decanoate
Sodium; 7-(2-hydroxy-benzoylamino)-heptanoate (SNAG)
Sodium; 6-(2-hydroxy-benzoylamino)-hexanoate (SNAJ)
Apixaban
Rivaroxaban
Ezetimibe
Similar related products
The products supplied by the company are only used for research and development. Except for the approval of the competent authority, it is strictly prohibited to be used in the production and sales of medicines, food and health products.
